the Predictive Value of Immune Cell in Locally Advanced Cervical Cancer
Conditions: Locally Advanced Cervical Carcinoma; Concurrent Chemoradiotherapy; Immunotherapy Interventions: Radiation: Nab-paclitaxel/Platinum, Sintilimab Sponsors: RenJi Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Cervical Cancer | Hospitals | Immunotherapy | Research